Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment

Eye (Lond). 2009 Nov;23(11):2140-2. doi: 10.1038/eye.2008.241. Epub 2008 Aug 1.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Choroidal Neovascularization / drug therapy*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Macular Degeneration / drug therapy*
  • Ranibizumab
  • United Kingdom

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Ranibizumab